Clin2
NCT07484893Worth exploringNot yet recruiting

Testing a new enzyme injection in healthy men

Healthy Adult Male

This trial tests whether a single injection of a new enzyme (called recombinant human hyaluronidase) is safe in healthy men. It helps break down a substance in the body, potentially making other injected medicines work better, but this study only checks safety and how the body handles it.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
24 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • Be a healthy man between 18 and 45 years old
  • Have a body mass index (BMI) from 18 to 28
  • Have no skin damage, tattoos, or marks at the injection site (usually the arm)
  • Be willing to use highly effective birth control with your partner during the study and for 3 months after, and not donate sperm
  • Have no significant medical conditions, recent infections, drug or alcohol issues, or use of certain medicines
  • Be able to follow study rules and attend all visits

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07376200Recruiting· Phase 1
First-in-human study of a new injection (HEC-151)

This study tests a new injection called HEC-151 in healthy men to see how it affects the body at different single doses. It's one of the first steps to see if the drug is safe and could one day help people with diabetes or related conditions.

Chongqing, Bishan
NCT07102251Recruiting· Phase 1
Safety study of HEC-007 injection in healthy and overweight people

This trial tests a new injection, HEC-007, to see if it is safe in healthy adults and in people who are overweight or obese. It may help with weight management and related health issues.

Hefei, Anhui
NCT07516639Not yet recruiting· Phase 1
Testing a new drug for safety in healthy adults

This study tests a new investigational drug called ISH0613 in healthy volunteers to see if it is safe and how the body processes it. It is the first time this drug is given to humans.

Nanjing, Jiangsu
NCT07861581Not yet recruiting· Phase 1
Testing a new injection for safety in healthy adults

This trial tests a new drug called QLS2312, given as an injection, to see if it is safe and how the body handles it. It is an early study in healthy volunteers that helps decide if the drug can be studied in people with certain conditions.

NCT07483437Not yet recruiting· Phase 1
Study of HS-20136-2 in healthy people

This study tests a new medicine called HS-20136-2 in healthy volunteers. It aims to see how safe the medicine is and how the body processes it.

Adelaide, South Australia
NCT07790783Not yet recruiting· Phase 1
Healthy volunteer study of a new injection (phase 1)

This is a first-in-human study of a new injected medication that may help with certain conditions. The trial is looking for healthy volunteers to check the drug's safety and how it works in the body.

Beijing, Beijing Municipality

Hear when a new Healthy Adult Male trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.